1. Home
  2. ADCT vs SGU Comparison

ADCT vs SGU Comparison

Compare ADCT & SGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADCT
  • SGU
  • Stock Information
  • Founded
  • ADCT 2011
  • SGU 1995
  • Country
  • ADCT Switzerland
  • SGU United States
  • Employees
  • ADCT N/A
  • SGU N/A
  • Industry
  • ADCT Biotechnology: Pharmaceutical Preparations
  • SGU Other Specialty Stores
  • Sector
  • ADCT Health Care
  • SGU Consumer Discretionary
  • Exchange
  • ADCT Nasdaq
  • SGU Nasdaq
  • Market Cap
  • ADCT 380.2M
  • SGU 390.2M
  • IPO Year
  • ADCT 2020
  • SGU 1995
  • Fundamental
  • Price
  • ADCT $4.54
  • SGU N/A
  • Analyst Decision
  • ADCT Strong Buy
  • SGU
  • Analyst Count
  • ADCT 6
  • SGU 0
  • Target Price
  • ADCT $7.80
  • SGU N/A
  • AVG Volume (30 Days)
  • ADCT 1.1M
  • SGU 35.6K
  • Earning Date
  • ADCT 11-06-2025
  • SGU 08-06-2025
  • Dividend Yield
  • ADCT N/A
  • SGU 6.20%
  • EPS Growth
  • ADCT N/A
  • SGU 33.71
  • EPS
  • ADCT N/A
  • SGU 1.66
  • Revenue
  • ADCT $77,246,000.00
  • SGU $1,777,057,000.00
  • Revenue This Year
  • ADCT $13.47
  • SGU N/A
  • Revenue Next Year
  • ADCT $5.88
  • SGU N/A
  • P/E Ratio
  • ADCT N/A
  • SGU $7.14
  • Revenue Growth
  • ADCT 15.73
  • SGU N/A
  • 52 Week Low
  • ADCT $1.05
  • SGU $10.84
  • 52 Week High
  • ADCT $4.67
  • SGU $13.75
  • Technical
  • Relative Strength Index (RSI)
  • ADCT 74.76
  • SGU 50.49
  • Support Level
  • ADCT $4.15
  • SGU $11.73
  • Resistance Level
  • ADCT $4.67
  • SGU $11.94
  • Average True Range (ATR)
  • ADCT 0.25
  • SGU 0.16
  • MACD
  • ADCT 0.08
  • SGU 0.02
  • Stochastic Oscillator
  • ADCT 82.86
  • SGU 53.85

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

About SGU Star Group L.P.

Star Group LP is a company engaged in providing home heating products and services to residential and commercial customers. The company offers heating oil and air conditioning equipment, as well as home security and plumbing services. The company also sells diesel fuel, gasoline, and home heating oil. Geographically, the company operates in U.S.

Share on Social Networks: